Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Age-specific prevalence of human papilloma virus infection among Nigerian women
BMC Public Health, Volume 14, No. 1, Article 656, Year 2014
Notification
URL copied to clipboard!
Description
Background: Inconsistent trends in HPV prevalence by age have been described in Africa. We examined the age prevalence pattern and distribution of 37 HPV-DNA types among urban Nigerian women. Methods. The study population was a sample of 278 women who presented to cervical cancer screening programs in Abuja, Nigeria, between April and August 2012. Using a nurse administered questionnaire, information on demographic characteristics and risk factors of cervical cancer was collected and samples of cervical exfoliated cells were obtained from all participants. Roche Linear Array HPV Genotyping Test® was used to characterize prevalent HPV and log-binomial regression models were used to examine the association between potential correlates and the prevalence of HPV infection. Results: The mean age (SD) of the women enrolled was 38 (8) years. The overall prevalence of HPV was 37%. HPV 35 was the most prevalent HPV type in the study population. Among women age ≤ 30 years, 52% had HPV infection compared to 23% of those women who were older than 45 years (p = 0.006). We observed a significant linear association between age and the prevalence of HPV infections. The prevalence ratio (PR) and 95% confidence interval (CI) was 2.26 (1.17, 4.34) for any HPV infection, 3.83 (1.23, 11.94) for Group 1 HPV (definite carcinogens), and 2.19 (0.99, 4.84) for Group 2a or 2b HPV (probable or possible carcinogens) types, among women aged 18-30 years, compared to women who were older than 45 years. Conclusion: The prevalence of HPV infection was highest among younger women and decreased steadily with age among this population of urban Nigerian women. © 2014 Akarolo-Anthony et al.; licensee BioMed Central Ltd.
Authors & Co-Authors
Akarolo-Anthony, Sally N.
United States, Boston
Harvard T.h. Chan School of Public Health
Nigeria, Abuja
Institute of Human Virology - Nigeria
Famooto, Ayotunde O.
Nigeria, Abuja
Institute of Human Virology - Nigeria
Dareng, Eileen O.
Nigeria, Abuja
Institute of Human Virology - Nigeria
Olaniyan, Olayinka Babafemi
Nigeria, Abuja
National Hospital, Abuja
Offiong, Richard A.
Nigeria, Abuja
University of Abuja
Wheeler, Cosette Marie
United States, Albuquerque
Unm Health Sciences Center
Adebamowo, Clement
United States, Boston
Harvard T.h. Chan School of Public Health
Nigeria, Abuja
Institute of Human Virology - Nigeria
United States, Baltimore
University of Maryland School of Medicine
Statistics
Citations: 63
Authors: 7
Affiliations: 6
Identifiers
Doi:
10.1186/1471-2458-14-656
e-ISSN:
14712458
Research Areas
Cancer
Genetics And Genomics
Health System And Policy
Study Design
Cross Sectional Study
Study Locations
Nigeria
Participants Gender
Female